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Summary Low-level direct electric current has been shown to be capable of destroying tumour tissue. Using
an early-passage subcutaneous murine mammary carcinoma, the relationships between the volume of tumour
destruction, charge and polarity have been examined. The results revealed a direct correlation between charge
passed and absolute volume regression when the intratumoral electrode was made either an anode or a
cathode. Tumour destruction for a given charge was significantly greater following anodic than cathodic
treatment. A direct correlation was also observed between the percentage volume of prompt treatment-induced
regression and the in situ end point of tumour growth delay. During the course of these experiments, a highly
reproducible toxic effect was discovered, which has not been previously reported for this modality. An anodic
charge greater than 10.6 coulombs or a cathodic charge greater than 21.6 coulombs resulted in 100% mortality
at 24-72 h, while lower charges had no influence on mortality. Quantitative assays of a number of blood
parameters showed that mortality was associated with serum electrolyte imbalances and appeared to be the
result of the metabolic load of tumour breakdown products. These effects are similar to the tumour lysis or
surgical crush syndromes and should not constitute a significant problem in clinical practice, where the tumour
mass to total body mass ratio will normally be much smaller.
Direct current therapy (DCT) offers considerable promise as
a low-cost, minimally invasive anti-tumour treatment. While
the tissue-destructive effects of low, direct electrical currents
have been known for many years, development of a clinically
acceptable therapy has been slow, hindered, for example, by
uncertainties regarding the quantitation of the dose-response
relationship. Our previous qualitative study demonstrated
that both anodic and cathodic treatments caused prompt and
massive tumour necrosis (Dodd et al., 1993). The present
work provides an absolute and relative quantitation of the
extent of tumour regression/necrosis with charge and
polarity. In common with previous workers, we noted that
tumour lysis and volume decrease was extremely rapid after
DCT. For other therapies, it has been observed clinically that
an undesirable 'tumour lysis syndrome' may result in these
circumstances (van der Hoven et al., 1992). Accordingly, we
also examine here the potential systemic consequences of
treating tumours by DCT.
Materials and methods
All procedures to be described complied with the Animals
(Scientific Procedures) Act 1986 (UK). Male B6DF21 (Pater-
son) mice, 6-8 weeks old, weight approximately 25 g, were
inoculated subcutaneously with a suspension of cells from a
low-passage, syngeneic murine mammary carcinoma, T50/80
(Moore, 1988). Tumours were treated by DCT 6-10 weeks
after inoculation when they were approximately spherical and
6-1O mm in diameter. Tumour size was assessed using ver-
nier calipers to measure three orthogonal diameters a, b and
c. Tumour volume was calculated using the approximation:
V' itabc/6
Up to four mice were treated simultaneously while held
under general anaesthesia and maintained at a constant
temperature of 37°C. Anaesthesia was induced by i.p. injec-
tion of ketalar (Park Davis, Pontypool, UK) and maintained
using halothane (ICI Pharmaceuticals, Alderley Edge, UK)
and oxygen inhalation for the duration of the procedure.
Each animal was placed on a copper plate electrode covered
in conducting gel (Dracard, Maidstone, UK). The second
electrode consisted of a 1 cm length of gold wire, 0.25 mm
diameter, spot welded to an 8 cm length of phosphor-bronze
wire. This was inserted into the tumour through a 21 G
needle which was subsequently removed, and held firmly by a
supporting gantry above the mouse with the terminal gold
section only in contact with the tumour. A new gold elect-
rode was used after every 2-3 treatments, thus minimising
the effects of gradual roughening of the electrode surface due
to dissolution of gold when the electrode was made an
anode. Before use as anode or cathode, these intratumoral
electrodes were sterilised with 70% alcohol. Direct current
was passed between the electrodes by means of a computer-
controlled, constant-current power supply which continually
monitored voltage. The power source used here was designed
to maintain a constant current; applied voltage was therefore
automatically varied accordingly within the range 1-16 V.
For an implanted anode, current and duration of application
varied from 1 to 4 mA and 30 to 90 min respectively. For the
cathode, values were 1-5 mA and 30-90 min. Different
limits of total charge delivered during anodic and cathodic
treatments were imposed by mortality of the animals (see
below). Animals were randomly allocated to a current-
time-polarity treatment group, with seven test animals and
one control animal per group. Controls were exposed to
anaesthesia and implantation of the electrode, but no current
was passed. After treatment animals were housed in indivi-
dual cages. Each tumour was measured daily until it had
grown to 125% of its pretreatment volume, when the animal
was killed using a schedule 1 method.
The initial volume of control tumours varied over the same
range as did treated tumours, and this enabled data from
controls to be used in a computer program that generated
idealised tumour growth curves for any initial tumour
volume within that range. Using this program, (i) maximum
decrease in tumour volume and (ii) tumour regrowth delay
were calculated for each treated tumour, relative to the size-
matched control curve. In some cases the decrease in volume
was equal to the total initial volume, and in a few cases no
regrowth of the tumour was observed, even after several
months, i.e. the animals were 'cured' of their tumours. How-
ever, in this first series, only those tumours in which partial
damage (i.e. less than total volume regression) occurred were
used to quantify the effects of treatment. In those tumours in
which the relative volume regression was 100%, the absolute
volume regression attainable for that dose was unknown.
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Using the same methods as above, further groups of animals
were treated with higher charges. Groups were either (i)
sacrificed at different times after treatment and their organs
subjected to histological examination or (ii) placed under
deep terminal anaesthesia, blood taken and biochemical
analysis of blood parameters carried out ('Cobras Mira-S'
analyser; Roche, Welwyn Garden City, UK).
Statistical methods used were as follows: For calculation of
volume regression versus charge and growth delay versus
percentage volume regression, a linear-linear regression
yielded the best (least-squares) fit to the data. Analysis of
biochemical data (treated-untreated) was made by a two-
sample t-test, significance being taken as P = 95% or
greater.
Results
Anodic treatment
When volume regression was analysed against various
parameters of dose delivered, the best correlation was
obtained when plotted against charge, although it did appear
that higher currents resulted in greater volume regression for
the same charge passed, possibly because of higher rates of
production of electrolytic products (see Discussion). Regres-
sion analysis of the data showed a linear relationship
between the volume of regression induced in the tumour and
the charge passed when the electrode in the tumour was an
anode (Figure 1). The line of best fit is given by the linear
equation:
V= (50 ±2)C + (18 ± 15) (r = 0.930, P,I,pe <0.001, n = 76)
Where V is the volume in mm3 and C is the charge in
coulombs. A measure of the efficacy of an anti-tumour
therapy in experimental animals is provided by the growth
delay induced in the tumour by that therapy. With a
localised therapy such as DCT one would expect growth
delay to be dependent on the proportion of the tumour
volume destroyed. Regression analysis of the experimental
data showed a linear relationship, the line of best fit being
given by the equation:
G = (0.20 ± 0.01)D + 1.4 ± 0.5 (r = 0.925, PS10p, <0.001, n = 76)
where G is the growth delay in days and D is the maximum
percentage volume decrease.
Cathodic treatment
Regression analysis of the data obtained on cathodic treat-
ment of the tumours again showed a linear relationship
(Figure 1) between volume of tumour regression and charge.
The line of best fit is given by the equation:
V= (33 ± 2)C + 38 ± 16 (r = 0.87, P,10pe<0.001, n = 108)
Similarly, for growth delay and percentage volume
decrease:
G=(0.16±0.01)D+2.1±0.4 (r=0.85, P,IP,Z <0.001, n = 108)
Note that when the gold electrode was made a cathode, the
remote copper plate, which then became an anode, showed
evidence of dissolution with (non-traumatic) traces of a green
cupric chloride deposit visible on the animal's skin by the end
of treatment.
Treatment-induced mortality
During the course of the experiments described above, the
effects of higher dose could not be examined, owing to
mortality of the animals. Consequently, experiments were
carried out to determine the onset and cause of this mortality
which, to our knowledge, has not been previously reported.
Tumour-bearing animals were randomly assigned to one of
eight groups, each containing six mice. Two groups were
used as controls and underwent anaesthesia and implantation
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Figure 1 Volume regression (pretreatment minus nadir) induced
in T50/80 tumours as a function of electrical charge passed, with
the inserted electrode either anodic (a) or cathodic (b). Individual
data points and linear least-squares fit.
of the electrode, but no current was passed. The remaining
groups received either anodic or cathodic treatment with
4 mA for 60 min (14.4 C), 3 mA for 90 min (16.2 C) or 7 mA
for 60 min (25.2 C). All animals made a good recovery from
the anaesthetic and treated animals could not be distin-
guished from controls for the first 12 h. From 12 h onwards,
all anode-treated groups and the 25.2 C cathode-treated
group began to exhibit signs of abnormal behaviour, becom-
ing hypothermic with decreased motor tone. From incidental
deaths in the earlier experiments, it was known that all these
animals would die within 72 h of treatment, with most
animals dying between 24 and 48 h. Animals in the other
groups showed no untoward effects. Histological examination
of internal organs was performed on further groups of
animals, treated in the same way but sacrificed within 10 min
of completion of treatment (Oh) or at 12, 24, 48 or 72 h
later. However, no macroscopic or light microscopic signs of
organ damage could be found to explain the observed toxic
effects.
Biochemical analysis ofblood
Animals were randomly allocated to one of seven groups,
each containing 16 mice. The treatments received by each
group are shown in Table I. At specified times after treat-
ment, blood was taken under terminal anaesthesia and
analysed biochemically for a number of clinically relevant
parameters (Table I). Immediately after treatment with a
subsequently lethal dose via either anode or cathode, the
blood profile varied little from that of control animals. By
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Table I Biochemical changes in the blood of mice exposed to DCT. 0 h = within 10 min of completion of treatment. Errors expressed as
1 s.d.
Anode
Electrode Control (A)
Dose (coulomb) 0 14.4
Time to sampling (h) 0 0
Na (mmoll') 142.3 4.0 141.9 3.8 12
K (mmol l') 4.56 0.45 4.78 0.93 10
Ca (mmoll') 1.96 0.14 1.93 0.13 1
Creatinine (mgl') 15.8 5.4 13.9 7.7 9
Urea (mgl-') 6.6± 1.6 6.9± 1.5 3
Glucose (mgl') 9.6± 1.2 9.7± 1.6
*0.01> P >0.001, **0.001 >P >0.0001, ***0.0001 > P.
Cathode
A (C) C C C
14.4
24
9.3 ± 7.3***
).25 ± 1.51 **
.44 ± 0.25***
)6.3 ± 23.0***
4.2± 6.4***
5.4± 1.2***
24 h certain highly specific and reproducible changes had
occurred (Table I), namely low serum sodium, high serum
potassium, low serum calcium, low plasma glucose, raised
blood urea and raised serum creatinine. While these changes
were induced by an anodic charge of 14.4 C, a similar
cathodic charge, which was non-lethal, induced no significant
change at either 24 or 48 h after treatment. The time interval
between treatment and death in this system is the same
regardless of whether a subsequently lethal anodic or subse-
quently lethal cathodic treatment is used and is accompanied
by destruction of a tumour volume >700mm3 (Figure 1).
Discussion
It has been known since the late nineteenth century that
low-level direct electrical current can destroy tumour tissue
and inhibit tumour growth. Several workers have demon-
strated the efficacy of this modality against subcutaneous
animal tumour models (Humphrey & Seal, 1959; Schaube et
al., 1977; David et al., 1985; Marino et al., 1986) and its
potential clinical application (Nordenstrom, 1983). We have
now examined the quantitative relationships between tumour
destruction and DCT 'dose'. The results demonstrate a linear
relationship between the volume of regression induced and
the quantity of charge passed. Moreover, our comparison of
the effects of polarity of the electrode implanted in the
tumour demonstrates the greater efficacy of the anode over
the cathode, the slopes of the lines being 50 ± 2 and
33 ± 2 mm3 coulomb-' respectively. These values can be
compared with previously reported values of 21.1 and
22.6 mm3 coulomb-' for anodic treatment of rabbit liver and
lung respectively (Samuelsson et al., 1980). These authors
also reported that cathodic injury was less extensive for any
given charge passed. In contrast, cathodic treatment of a
fibrosarcoma Sa-1 or melanoma B-16 in mice was reported to
be more effective than anodic treatment (Miklavcic et al.,
1992). However, in this case the charges passed were < 1 mA
and the tumours were treated at a volume of only about
50mm3.
The tumour growth delay resulting from DCT is directly
proportional to the volume percentage of the tumour de-
stroyed by that treatment. Again, the slope of the line for
anodic treatment is greater than that for cathodic treatment,
the difference being statistically significant at the 95%
confidence level. This may reflect the different mechanisms of
damage occurring at the positive and negative electrodes.
When the treatment electrode is an anode, the following
reactions take place:
3H2O-2e-*2H30+ + 1/202
2C1 --2e -*C12
In addition to these, there is the anodic dissolution of
gold:
Au + C[- AuCl + e
Au + 4Ch-+AuCW4- + 3e
14.4
0
137.0 ± 5.1*
5.79 ± 1.23*
1.86 ± 0.21
22.8 ± 10.0
7.4 ± 2.7
8.1 ± 2.2
14.4
24
143.4 ± 2.6
5.12 ± 0.94
1.87 ± 0.08
29.0 ± 17.1*
6.4 ± 2.3
8.5 ± 1.0*
14.4
48
142.9 ± 3.1
4.82 ± 0.97
1.91 ± 0.15
20.3 ± 2.9*
6.1 ± 1.1
6.4± 1.5***
25.2
24
129.2 ± 7.4***
7.78 ± 1.89***
1.43 ± 0.27***
48.1 ± 28.6**
19.9 ± 5.7***
3.1 ± 1.5***
Whereas at the cathode, the main electrode reaction at the
surface is:
2H20 + 2e+H2 + 20H-
Mechanistically, if the damage to the tumour at each
electrode site were primarily due to local pH changes caused
by these reactions, one would expect a ratio corresponding to
the square root of the expression D(H3O)/D(OH-), where D
is the diffusion coefficient. This corresponds approximately to
1.4. Our results indicate a ratio of 50/33 = 1.5, which is close
to that predicted.
Previous measurements of the effects of photodynamic
therapy (PDT), another modality in which the extent of
necrosis predicts growth delay in this tumour model, gave a
slope of 0.29 ± 0.03 (Moore et al., 1989), compared with
0.20 ± 0.01 anode, 0.16 ± 0.01 cathode (this paper). How-
ever, this apparently significant difference in the efficacy of
PDT compared with DCT may at least in part be-due to the
different methods of estimating the proportion of damage. In
the case of PDT, volume of tumour necrosis was measured 1
day post treatment by proton magnetic resonance imaging.
For DCT, tumour volume was calculated daily from
measurement of orthogonal diameters, with minimum
volume seen at 3-5 days.
In the present experiments, results were compared irrespec-
tive of rate of delivery of the charge, since there was no
evidence of any influence of dose rate. If the method is to be
used to destroy larger tumour volumes, it may be necessary
to use higher currents in order to keep treatment times within
acceptable limits. From other work (Samuelsson & J6nsson,
1980) there appears to be no hyperthermic effect for currents
below about 80 mA. Thus, it is possible that dose rate effects
might become significant on using currents that were an
order of magnitude higher.
Determination of the relationships between treatment by
direct current and biological response in our experimental
model was limited by the mortality of the animals at higher
charges. This was found to be a highly reproducible effect,
occurring at or above 14.4 C in anode-treated animals and
25.2 C in cathode-treated animals. While no gross changes
could be detected in the internal organs of animals subjected
to what proved to be a lethal dose, profound changes in
blood chemistry were observed (Table I). As noted, the time
interval between treatment and death was the same whether
induced by anodic or cathodic treatment, and occurred when
destruction of tumour volume exceeded 700 mm3. The experi-
ment was conducted so that treatment resulted in destruction
of minimal normal tissue (overlying skin only) and this
would therefore contribute little to the observed mortality.
All mice used were of approximately the same weight (25 g),
and death occurred when destruction of tumour exceeded
approximately 0.7 g. The independence of effect from
polarity may suggest that the biochemical changes are related
more to the mass of tissue undergoing necrosis than to the
precise local mechanism inducing that necrosis. As in most
murine studies, in these experiments the ratio of tumour mass
to body mass is relatively high. Sudden necrosis of a large
proportion of that tumour would impose a high metabolic
burden on the kidney. Such a picture is seen clinically in the878 D.T. GRIFFIN etal.
tumour lysis syndrome (usually in treated systemic tumours)
and surgical crush syndrome (Better, 1990; van der Hoven et
al., 1992). In both cases, rapid breakdown of tissue leads to
release into the blood of intracellular protein, nucleic acid
and their breakdown products, many of which are capable of
inducing acute renal failure. In addition, intracellular potas-
sium is released in massive quantities and, with renal excre-
tion of that ion greatly reduced, a profound hyperkalaemia
results which may be sufficient to induce fatal cardiac arr-
hythmias. The mortality reported here is indicative of how
effective DCT is in destroying tumour tissue and does not
reflect a specific adverse effect of the therapy itself. In clinical
practice, the tumour load would, in most cases, be
insufficient to result in any adverse effects through such a
mechanism. Since the DCT treatment is localised rather than
systemic, possible adverse effects could be avoided, for exam-
ple by fractionated treatment, the relative efficacy of which
we are currently measuring in the preclinical model.
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